Community/Retail

Coffee drinkers with genetic polymorphisms may not need to be concerned with their coffee consumption based on new research.

Naturally produced melatonin tends to decrease with advancing age, so supplementation is a potential intervention for metabolic syndrome.

Do you ever fear that you are growing complacent, and unprepared for any kind of change?

Pharmacists should ask themselves, is what got you where you are today going to get you where you want to go?

The American Journal of Medicine has published a new article that describes the reemergence of neurosyphilis, and identifies HIV coinfection in individuals in Western countries as a key risk factor.

Prescription Verification is a critical step in the filling process. We should talk about it more with our students and colleagues.

In this clip, Karishma Patel, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, explains how finding the right mentors can help pharmacy student to achieve a healthy work-life balance.

The 2018 World Congress of Pharmacy and Pharmaceutical Sciences, hosted by the Royal Pharmaceutical Society, is scheduled for Sept. 2-6 in Glasgow, Scotland.

Thousands of pharmacists were polled for their over-the-counter recommendations in a variety of categories. The picks showed that although they aren’t all in agreement, pharmacists do have some clear favorites when it comes to OTC products for treating coughs, colds, and seasonal allergies.

Vibriosis infections most commonly occur through consumption of raw or undercooked seafood.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

New research suggests psychiatric diseases, including ADHD, that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.

Many patients are starting to record their doctors appointments, and some companies are looking to make this a smoother process.

Varicella-zoster virus can develop into or present as herpes zoster ophthalmicus. Clinicians need to initiate oral antiviral therapies within 72 hours of the onset of ocular involvement.

Studying for the MPJE can be daunting. Numerous online threads offer advice on where to start

Studies suggest vitamin D deficiency is associated with higher risk of pain, so shouldn’t vitamin D supplementation decrease pain?

Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company.

Basket studies can be useful to determine if a drug targeting a certain genetic mutation at a particular site may be effective in treating that same genetic mutation found in cancer located in another site of the body.

Being prepared is vital to understanding and resolving future drug shortages.

Tobacco is the leading cause of premature mortality among adults living with HIV.

EPS has released a new 10-pack configuration for all 4 sizes of its Steri-Dropper® sterile ophthalmic dispensing containers.

A new device intended to treat breathing difficulty associated with severe emphysema has been approved by the FDA.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Amazon will start prescription delivery with a focus on customer service and convenience.

Researchers at the University of Virginia developed an app called PositiveLinks to test out whether interactive smartphone functions and reminders could have a real-world impact on the health of HIV-positive patients.

The FDA voted against recommendign oxycodone extended-release capsules (REMOXY ER, Pain Therapeutics) for approval for the management of pain severe enough to require long-term, around-the-clock opioid treatment, during a joint meeting of the agency’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), and the Drug Safety and Risk Management Advisory Committee (DSARM).

The FDA has granted approval to Array BioPharma’s encorafenib (Braftovi) capsules in combination with binimetinib (Mektovi) tablets for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E or BRAFV600K mutation.